DE69420087T2 - Pharmazeutische Tablette geeignet zur gestuften Freisetzung von Wirkstoffen - Google Patents

Pharmazeutische Tablette geeignet zur gestuften Freisetzung von Wirkstoffen

Info

Publication number
DE69420087T2
DE69420087T2 DE69420087T DE69420087T DE69420087T2 DE 69420087 T2 DE69420087 T2 DE 69420087T2 DE 69420087 T DE69420087 T DE 69420087T DE 69420087 T DE69420087 T DE 69420087T DE 69420087 T2 DE69420087 T2 DE 69420087T2
Authority
DE
Germany
Prior art keywords
active ingredient
pharmaceutical tablet
active substances
upper layer
gradual release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69420087T
Other languages
English (en)
Other versions
DE69420087D1 (de
Inventor
Ubaldo Conte
Manna Aldo La
Lauretta Maggi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Jagotec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec AG filed Critical Jagotec AG
Publication of DE69420087D1 publication Critical patent/DE69420087D1/de
Application granted granted Critical
Publication of DE69420087T2 publication Critical patent/DE69420087T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
DE69420087T 1993-05-31 1994-05-20 Pharmazeutische Tablette geeignet zur gestuften Freisetzung von Wirkstoffen Expired - Lifetime DE69420087T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT93MI001120A IT1264517B1 (it) 1993-05-31 1993-05-31 Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati

Publications (2)

Publication Number Publication Date
DE69420087D1 DE69420087D1 (de) 1999-09-23
DE69420087T2 true DE69420087T2 (de) 2000-03-23

Family

ID=11366293

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69420087T Expired - Lifetime DE69420087T2 (de) 1993-05-31 1994-05-20 Pharmazeutische Tablette geeignet zur gestuften Freisetzung von Wirkstoffen

Country Status (13)

Country Link
US (2) US5487901A (de)
EP (1) EP0631775B1 (de)
JP (1) JPH07138150A (de)
AT (1) ATE183386T1 (de)
AU (1) AU677833B2 (de)
CA (1) CA2124553C (de)
DE (1) DE69420087T2 (de)
DK (1) DK0631775T3 (de)
ES (1) ES2138633T3 (de)
GR (1) GR3031841T3 (de)
IT (1) IT1264517B1 (de)
NZ (1) NZ260630A (de)
SI (1) SI0631775T1 (de)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
US6183778B1 (en) 1993-09-21 2001-02-06 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
US5534263A (en) * 1995-02-24 1996-07-09 Alza Corporation Active agent dosage form comprising a matrix and at least two insoluble bands
EP0812195B1 (de) * 1995-02-28 2002-10-30 Aventis Pharmaceuticals Inc. Arzneizubereitungen für piperidinalkanolderivate
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
IT1282650B1 (it) * 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
AU4219497A (en) * 1996-09-13 1998-04-02 Shionogi & Co., Ltd. Sustained-release preparation utilizing thermal change and process for the production thereof
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
PT998272E (pt) * 1997-08-26 2003-09-30 Aventis Pharma Inc Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
IN186245B (de) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US5843477A (en) * 1997-09-30 1998-12-01 Bayer Corporation Lubricants for use in tabletting
US6465009B1 (en) 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
US20090060995A1 (en) * 2005-01-13 2009-03-05 Kamalinder Kaur Singh Dispersible sustained release pharmaceutical compositions
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
EP1064937A1 (de) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmazeutische Zusammensetzungen mit kontrollierten Freigabe enthaltend ein Hypnotikum mit kurzer Wirkung oder deren Salze
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
AU2276801A (en) 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
AU2277101A (en) * 1999-12-20 2001-07-03 Schering Corporation Stable extended release oral dosage composition
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6372252B1 (en) 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US6955821B2 (en) 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1330236A2 (de) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Amoxicillinhaltige arzneizusammensetzungen
EP1245227A1 (de) 2001-03-31 2002-10-02 Jagotec Ag Pharmazeutische, im Magen aufschwimmende Tablette für die programmierte Freisetzung des Wirkstoffes und Verfahren zur Herstellung des in der Tablette enthaltenen schwimmfähigen Materials
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US20040156903A1 (en) * 2002-05-22 2004-08-12 Abrams Andrew L.. Metering and packaging of controlled release medication
US7052706B2 (en) * 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
EP1295926A1 (de) 2001-09-19 2003-03-26 ExxonMobil Chemical Patents Inc. Komponente für Klebstoffe und Verfahren zur deren Herstellung
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US20030104052A1 (en) * 2001-10-25 2003-06-05 Bret Berner Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
CA2409552A1 (en) * 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20030152622A1 (en) * 2001-10-25 2003-08-14 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral diuretic
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
ITMI20020515A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema per il rilasco controllato di uno o piu' principi attivi
ITMI20020514A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
US20060013875A1 (en) * 2002-05-29 2006-01-19 Impax Laboratories, Inc. Combination immediate release controlled release levodopa/carbidopa dosage forms
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
US7429619B2 (en) 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US20040115265A1 (en) * 2002-12-11 2004-06-17 Loutfy Benkerrour Multilayered tablet containing pravastatin and aspirin and method
PE20050335A1 (es) * 2003-08-07 2005-06-01 Sb Pharmco Inc Forma de dosificacion oral que comprende 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona y procedimiento para la preparacion
EP1663175B1 (de) * 2003-09-19 2012-03-28 Sun Pharma Advanced Research Company Limited Orales arzneimittelabgabesystem
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US7595335B2 (en) * 2003-10-28 2009-09-29 Pierre Fabre Medicament Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
FR2861299B1 (fr) 2003-10-28 2006-01-27 Pf Medicament Compositions pharmaceutiques a base de derives d'idasoxan sous formes polymorphes
US8476307B2 (en) * 2003-10-28 2013-07-02 Pierre Fabre Medicament Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
US7318935B2 (en) * 2004-05-21 2008-01-15 Accu-Break Technologies, Inc. Pharmaceutical tablets with active and inactive segments
JP4681843B2 (ja) * 2004-09-30 2011-05-11 日本臓器製薬株式会社 固形医薬製剤
US20090264495A1 (en) * 2005-02-17 2009-10-22 Standard Chem. & Pharm. Co., Ltd. Oral sustained-release pharmaceutical composition of indapamide, production and use thereof
US20060182803A1 (en) * 2005-02-17 2006-08-17 Standard Chem. & Pharm. Co., Ltd. Oral sustained-release pharmaceutical composition of indapamide, production and use thereof
US20060243809A1 (en) * 2005-04-27 2006-11-02 Hodgson Rodney T Combination logo and identification code
WO2007058660A1 (en) * 2005-11-18 2007-05-24 Accu-Break Technologies, Inc. Segmented pharmaceutical dosage forms
US20090087483A1 (en) * 2007-09-27 2009-04-02 Sison Raymundo A Oral dosage combination pharmaceutical packaging
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
EP2242485A4 (de) * 2008-02-15 2013-05-08 Sun Pharma Advanced Res Co Ltd Tablette mit gesteuerter freisetzung
US20100233259A1 (en) * 2008-12-12 2010-09-16 Pascal Grenier Dosage form of ropinirole
US10485770B2 (en) 2009-12-21 2019-11-26 Aptapharma, Inc. Functionally-coated multilayer tablets
WO2011085022A1 (en) * 2010-01-05 2011-07-14 Microdose Therapeutx, Inc. Inhalation device and method
BR112012030708A2 (pt) * 2010-06-01 2016-11-01 Grünenthal S A composições farmacêuticas do ibuprofeno e um antagonista do receptor h2
AU2012277375A1 (en) * 2011-06-29 2014-01-30 Sun Pharmaceutical Industries Limited Multilayered dosage form
GB201303781D0 (en) 2013-03-04 2013-04-17 Gauthier Pierre Pascal Oral timer device and method of using same
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
EP3782614A1 (de) 2013-10-07 2021-02-24 Impax Laboratories, LLC Mukoadhäsive levodopa-formulierungen mit gesteuerter freisetzung und/oder levodopa-ester und verwendungen davon
CA2987114A1 (en) 2015-06-03 2016-12-08 Triastek, Inc. Method of 3d printing oral dosage forms having a drug in a compartment sealed by an erodibleplug
US11278506B2 (en) 2015-10-09 2022-03-22 Rb Health (Us) Llc Pharmaceutical formulation
RU2602681C1 (ru) * 2015-11-09 2016-11-20 Федеральное государственное бюджетное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (ФГБОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России) Способ получения капсул диклофенака
MX2019006742A (es) 2016-12-09 2019-09-05 Bayer Animal Health Gmbh Preparacion farmaceutica y metodo para su fabricacion.
WO2018137686A1 (en) * 2017-01-26 2018-08-02 Triastek, Inc. Dosage forms of controlled release at specific gastrointestinal sites
USD907235S1 (en) * 2017-09-18 2021-01-05 University Of Hertfordshire Higher Education Corporation Enclosure for dissolution system
US11571391B2 (en) 2018-01-09 2023-02-07 Triastek, Inc. Oral drug dosage forms compromising a fixed-dose of an ADHD non-stimulant and an ADHD stimulant
WO2020255837A1 (ja) * 2019-06-17 2020-12-24 東和薬品株式会社 時限式溶出マスキング粒子およびそれを含有する経口医薬組成物
CN115624125B (zh) * 2022-10-28 2024-03-08 广州王老吉大健康产业有限公司 一种泡腾片及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2100858B1 (de) * 1970-07-03 1975-06-06 Daiichi Seiyaku Co
EP0230654B1 (de) * 1985-12-28 1992-03-18 Sumitomo Pharmaceuticals Company, Limited Arzneimittel mit verzögerter stossweiser Freisetzung
IT1201136B (it) * 1987-01-13 1989-01-27 Resa Farma Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive

Also Published As

Publication number Publication date
AU6342694A (en) 1994-12-08
CA2124553C (en) 2000-04-18
DE69420087D1 (de) 1999-09-23
AU677833B2 (en) 1997-05-08
ITMI931120A0 (it) 1993-05-31
IT1264517B1 (it) 1996-09-24
EP0631775B1 (de) 1999-08-18
JPH07138150A (ja) 1995-05-30
ITMI931120A1 (it) 1994-12-01
SI0631775T1 (en) 2000-02-29
CA2124553A1 (en) 1994-12-01
ATE183386T1 (de) 1999-09-15
ES2138633T3 (es) 2000-01-16
EP0631775A1 (de) 1995-01-04
GR3031841T3 (en) 2000-02-29
US5650169A (en) 1997-07-22
US5487901A (en) 1996-01-30
DK0631775T3 (da) 2000-03-06
NZ260630A (en) 1995-08-28

Similar Documents

Publication Publication Date Title
DE69420087D1 (de) Pharmazeutische Tablette geeignet zur gestuften Freisetzung von Wirkstoffen
DE69729134D1 (de) Pharmazeutische Tablette geeignet zur Wirkstofffreisetzung in aufeinanderfolgenden und vorherbestimmbaren Zeiträumen
DE69428862T2 (de) Linsenförmig pharmazeutische Tablette mit verzögerter Freigabe
DK156289D0 (da) Farmaceutisk praeparat indrettet til kontrolleret afgivelse af aktiv bestanddel
CA2316277A1 (en) Tablet for instant and prolonged release of one or more active substances
ATE269709T1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
IT1271122B (it) Composizioni farmaceutiche a rilascio controllato osmotico e per diffusione del farmaco e procedimento per la loro preparazione
CA2044398A1 (en) Programmed release oral solid pharmaceutical dosage form
DE69628444D1 (de) Säurelabile omeprazol enthaltende pharmazeutische zusammensetzung und verfahren zu dessen herstellung
CA2145513A1 (en) Pharmaceutical Tablet Capable of Liberating One or More Drugs at Different Release Rates
ATE68343T1 (de) Darreichungsform mit kontrollierter freigabe.
NO912470D0 (no) Fremgangsmaate til fremstilling av et komposittlag paa et underlag i et apparat som inneholder elektrolytt i fast tilstand.
DE69111822T2 (de) Arzneimittel zur gesteuerten freisetzung mit einer überzogenen seitlichen randfläche.
ATE212543T1 (de) Pharmazeutische zusammensetzung aus stabilisierten lipophilen matrizen mit kontrollierter wirkstofffreisetzung
DK101781A (da) Fremgangsmaade til fremstilling af 10/substituerede 5-cyamethylen-dibenzo (a,d) cycloheptener
IT1244037B (it) Forma farmaceutica a rilascio selettivo nel colon

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: SEITZ, R., DIPL.-ING.UNIV., PAT.-ANW., 80538 MUENC